Sell-rated reports

287 tickers rated Sell
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Helmerich & Payne, Inc.
HP·Energy
D ★Strong Sell
Current$31.77
Nov 21, 2026

Helmerich & Payne's advanced drilling fleet and improving U.S. margins offer cyclical recovery potential, but Saudi Arabian impairments, weak capital returns, and demanding cash-flow growth expectations undermine its investment appeal.

Score
54
Advance Auto Parts, Inc.
AAP·Consumer Discretionary
D ★Strong Sell
Current$45.50
Nov 8, 2026

Advance Auto Parts offers a meaningful margin and cash-flow turnaround opportunity through distribution improvements, but persistent competitive disadvantages, weak capital returns, and leverage limit the investment appeal.

Score
54
WPP plc
WPP·Communication Services
D ★Strong Sell
Current$27.18
Nov 1, 2026

WPP could recover through integrated advertising services and Elevate28 cost savings, but persistent client losses, weak organic growth and substantial restructuring demands undermine confidence in durable earnings recovery.

Score
54
GameStop Corp.
GME·Consumer Discretionary
D ★Strong Sell
Current$21.81
Sep 15, 2026

GameStop has delivered a striking profitability turnaround and owns a valuable eBay stake, but shrinking core revenue, dilution and concentrated capital-allocation risk leave the case too dependent on management and outside assets.

Score
54
Humana Inc.
HUM·Healthcare
D ★Strong Sell
Current$433.74
Nov 9, 2026

Humana's improved Medicare Advantage Star Ratings support a potentially powerful earnings turnaround, but persistent medical-cost pressure and an elevated forward valuation make the recovery difficult to underwrite at the current price.

Score
53
Axcelis Technologies, Inc.
ACLS·Technology
D ★Strong Sell
Current$99.24
Nov 8, 2026

Axcelis offers specialized ion implantation technology, strengthening aftermarket revenue, and semiconductor-cycle recovery potential, but weak cash conversion, demanding valuation, and unresolved Veeco merger risks limit investment appeal.

Score
53
Lumen Technologies, Inc.
LUMN·Communication Services
D ★Strong Sell
Current$3.99
Nov 7, 2026

Lumen's enterprise networking transformation and AI-related connectivity demand offer turnaround potential, but legacy revenue erosion, heavy capital spending, and substantial debt continue to threaten sustainable shareholder returns.

Score
53
ASE Technology Holding Co., Ltd.
ASX·Technology
D ★Strong Sell
Current$39.50
Nov 1, 2026

ASE Technology Holding benefits from structural advanced packaging demand and improving semiconductor margins, but elevated valuation and exceptionally heavy capital spending threaten future shareholder returns.

Score
53
Polaris Inc.
PII·Consumer Discretionary
D ★Strong Sell
Current$58.64
Oct 29, 2026

Polaris's established powersports brands and improving market share offer cyclical recovery potential, but weak cash conversion, substantial leverage, and tariff-refund-supported earnings undermine the sustainability of its turnaround.

Score
53
Dr. Reddy's Laboratories Limited
RDY·Healthcare
D ★Strong Sell
Current$13.21
Oct 25, 2026

Dr. Reddy's diversified pharmaceutical franchise and growing India and emerging-market businesses offer long-term recovery potential, but North American generic erosion, manufacturing risks, and demanding earnings-based valuation limit investment appeal.

Score
53
Freedom Holding Corp.
FRHC·Financials
D ★Strong Sell
Current$178.85
Nov 9, 2026

Freedom Holding offers strong emerging-market financial-platform growth and cross-selling potential, but its premium valuation, weak cash conversion, and capital-intensive diversification create an unfavorable risk-reward profile.

Score
52